查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856524

局部麻醉劑市場按給藥途徑、藥物類別、產品類型、劑型、最終用戶、分銷管道和應用分類－全球預測，2025-2032年

Local Anesthesia Drugs Market by Route Administration, Drug Class, Product Type, Formulation, End-User, Distribution Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，局部麻醉劑市場規模將成長至 43.4 億美元，複合年成長率為 5.64%。

關鍵市場統計數據
基準年 2024 28億美元
預計年份：2025年 29.6億美元
預測年份 2032 43.4億美元
複合年成長率 (%) 5.64%

全面介紹了正在改變全球局部麻醉護理格局的臨床需求、製劑進步和商業性因素。

局部麻醉劑支持無數日常臨床操作，從常規牙科手術到門診和住院環境中複雜的局部麻醉手術。過去十年，藥物動力學、製劑和給藥系統的改進重新定義了人們對局部麻醉劑在手術全期流程中的戰略重要性。臨床醫生要求局部麻醉劑具有可預測的阻滯效果，且全身影響最小；管理者尋求在各種醫療環境中都能發揮其價值；而生產商則必須在創新、監管嚴格性和生產擴充性之間取得平衡。

分析重塑局部麻醉治療競爭格局的關鍵技術、臨床、供應鏈和數位健康變化。

近期趨勢已超越簡單的產品替代，涵蓋了局部麻醉的研發、生產、應用和報銷方式的根本性變化。製劑技術的進步正在研發出作用時間更長、靶向性更強的藥物，而聯合用藥方案和基於器械的給藥系統則使臨床醫生能夠根據每項手術的具體需求客製化麻醉方案。同時，人們越來越關注減少鴉片類藥物的使用和最佳化術後恢復途徑，這促進了跨學科合作，並提升了局部麻醉劑在多模態鎮痛策略中的作用。

深入分析2025年美國關稅如何改變了局部麻醉劑供應鏈的籌資策略、生產佈局和採購決策

2025年美國關稅政策對局部麻醉產品的生產、採購、定價策略和長期供應鏈規劃產生了連鎖反應。原料藥和關鍵輔料進口關稅的提高增加了到岸成本，並擠壓了依賴全球供應商的製造商的利潤空間。為此，採購團隊加快了尋找替代供應商的步伐，並擴大了雙重籌資策略，以降低單一國家供應中斷的風險。

整合給藥途徑、藥物類別、產品類型、劑型、終端用戶行為、分銷管道和臨床應用等因素，提供高級細分洞察，從而指導您的策略。

細分市場層面的動態變化揭示了產品開發和商業化策略中存在的細微機會和限制。從給藥途徑來看，臨床實踐區分了用於淺表手術的浸潤麻醉技術和需要精準、長效藥物的神經阻斷麻醉；局部和脊髓給藥要求產品具有可預測的擴散範圍和最小的全身毒性；而局部用藥製劑則強調快速起效和最小刺激性，適用於皮膚科和輕微牙科應用。每種給藥途徑都有其自身的臨床醫生培訓需求、器械相容性考慮因素和安全性特徵，這些因素都應影響製劑和包裝的選擇。

戰略區域視角，重點關注美洲、歐洲、中東和非洲以及亞太市場在監管預期、採購慣例和臨床應用方面的差異

區域差異持續對產品優先順序和市場推廣策略產生重要影響。在美洲，先進的臨床基礎設施、龐大的門診病人以及不斷提高的支付方期望共同推動了長效製劑、預填充系統以及支持減少鴉片類藥物使用方案的解決方案的發展。該地區的供應鏈策略體現了國內生產與依賴成熟國際供應商之間的平衡，採購團隊傾向於選擇那些能夠證明符合監管要求和物流可靠性的合作夥伴。

透過揭示創新者、非專利生產商、合約生產商和設備整合商之間的競爭格局，塑造局部麻醉劑開發和商業化的未來。

公司層面的動態反映了創新藥廠、非專利生產商、合約生產商和器材-藥物整合商之間的競爭關係。創新藥企持續投資於緩釋性化學技術和專有給藥平台，以在持續時間、安全性和給藥便利性方面實現差異化。這些投資通常輔以針對性的臨床項目，以證明其在特定手術終點和患者報告結果方面的益處。同時，學名藥生產商在商品化領域仍保持著重要的影響力，在這些領域，成本效益和供應可靠性是關鍵的採購促進因素，尤其是在牙科和基礎浸潤麻醉等大批量應用領域。

為製造商、供應商和醫療保健領導者提供優先考慮的實用建議，以增強供應鏈韌性、加速臨床應用並推動獲利成長。

產業領導者應採取一系列優先且切實可行的措施，以保障供應、加速產品推廣並維持利潤率。首先，應加強供應商多元化和庫存策略，以降低貿易政策波動和對單一供應商依賴的影響。投資區域性生產和委託製造方案，有助於快速回應區域需求變化，同時增強市場韌性。其次，應使研發重點與臨床路徑需求一致。這意味著應著重研發能夠提高手術效率、減少鴉片類藥物使用量並簡化門診和居家醫療的製劑。

採用穩健的混合調查方法，結合對臨床醫生和採購負責人的訪談、法規和專利分析以及供應鏈圖譜，對研究洞察檢驗。

本研究採用混合方法，確保分析的廣度和深度。主要研究包括對門診和住院臨床醫生、採購主管和供應鏈經理進行結構化訪談，以了解他們的實際偏好、痛點和採購標準。為了補充這些定性資訊，本研究還進行了監管審查和產品附加檔分析，以了解主要司法管轄區的核准途徑、附加檔差異和上市後承諾。製造和採購評估結合了供應商分佈圖、產能評估和情境分析，以檢驗在貿易政策和需求衝擊下的韌性。

這份簡明扼要的結論綜述將臨床優先事項、供應韌性和商業化需求連結起來，並概述了相關人員的策略要務。

總之，局部麻醉領域在基礎科學方面已趨於成熟，商業性和營運發展也充滿活力。療效、安全性和持續時間等臨床需求仍然是藥物選擇的指南原則，而製劑創新和給藥平台則為差異化提供了重要的機會。貿易政策的變化和供應鏈的重組凸顯了供應商多元化和區域化生產策略的重要性。在各個地區和醫療機構中，能夠將嚴謹的臨床證據與切實可行的給藥方式相結合，並在手術效率和患者療效方面展現出顯著價值的機構將取得最大的成功。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大脂質性局部麻醉劑配方，以降低全身毒性風險
  • 整合數位化監測平台以最佳化局部麻醉劑劑量和安全性
  • 增加對長效麻醉技術的投資，以實現更長的術後鎮痛
  • 超音波引導神經阻斷技術的應用將推動對緩釋性的需求。
  • 包含新型局部麻醉劑的非鴉片類多藥鎮痛通訊協定的出現
  • 提高新型、更安全、心臟毒性風險較低的醯胺類麻醉劑的核准
  • 在臨床實務中，緩釋性麻醉劑植入在慢性疼痛管理的應用日益廣泛。
  • 用於精確局部皮膚麻醉的經皮給藥系統的技術進步
  • 專業藥房分散式配發個人化局部麻醉劑混合物的成長
  • 製藥公司和醫療設備公司夥伴關係開發智慧麻醉劑輸送技術

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依給藥途徑分類的局部麻醉劑市場

  • 浸潤
  • 神經阻斷
  • 區域
  • 脊椎
  • 局部的

第9章局部麻醉劑市場（依藥物類別分類）

  • 醯胺
    • Bupivacaine
    • Lidocaine
    • Mepivacaine
    • Prilocaine
    • Ropivacaine
  • 酯
    • Benzocaine
    • 普魯卡因
    • 丁卡因

第10章局部麻醉劑市場（依產品類型分類）

  • 奶油
  • 凝膠
  • 注射
  • 修補
  • 噴

第11章局部麻醉劑市場（依劑型分類）

  • 多劑量管瓶
  • 粉末
  • 預填充式注射器
  • 單劑量安瓿

第12章 依最終用戶分類的局部麻醉劑市場

  • 門診手術中心
    • 獨立的
    • 醫院相關
  • 牙醫診所
  • 居家醫療
  • 醫院
    • 私立醫院
    • 公立醫院

第13章局部麻醉劑市場依通路分類

  • 醫院藥房
  • 網路藥房
    • 直接從製造商購買
    • 網路聚合器
  • 零售藥房
    • 鏈
    • 獨立的

第14章局部麻醉劑市場依應用領域分類

  • 牙科
  • 皮膚科
  • 耳鼻喉科
  • 眼科
  • 足病科

第15章 各地區局部麻醉劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章局部麻醉劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國局部麻醉劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
    • Sandoz International GmbH
    • Fresenius Kabi AG
    • Hikma Pharmaceuticals PLC
    • B. Braun Melsungen AG
    • Aspen Pharmacare Holdings Ltd.
    • Amneal Pharmaceuticals, Inc.
    • Sun Pharmaceutical Industries Ltd.
Product Code: MRR-742BD5180AE5

The Local Anesthesia Drugs Market is projected to grow by USD 4.34 billion at a CAGR of 5.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.80 billion
Estimated Year [2025] USD 2.96 billion
Forecast Year [2032] USD 4.34 billion
CAGR (%) 5.64%

Comprehensive introduction framing clinical imperatives, formulation advances, and commercial forces that are reshaping the global local anesthesia therapeutic landscape

Local anesthesia drugs underpin countless day-to-day clinical procedures, ranging from routine dental interventions to complex regional techniques in ambulatory and hospital settings. Over the past decade, improvements in pharmacokinetics, formulation science, and delivery systems have reframed expectations for efficacy, onset, and duration, while parallel shifts in clinical practice toward outpatient care and opioid stewardship have elevated the strategic importance of local anesthetics in perioperative pathways. Clinicians demand predictable blocks with fewer systemic effects, administrators seek value across care settings, and manufacturers must balance innovation with regulatory rigor and manufacturing scalability.

This introduction frames the current environment by connecting clinical imperatives with commercial realities. It highlights how incremental pharmaceutical innovations-such as extended-release formulations and user-friendly pre-filled systems-interact with broader themes including supply chain resilience, procurement consolidation, and changes in administration settings. The section emphasizes the interplay of evidence generation, clinician training, and reimbursement dynamics that collectively determine adoption curves. By positioning clinical performance, patient experience, and health-economic considerations as co-equal drivers of decision-making, this introduction sets the stage for a focused exploration of recent disruptions, regulatory influences, and actionable recommendations for stakeholders across the ecosystem.

Examination of pivotal technological, clinical practice, supply chain, and digital health shifts that have collectively redefined the competitive landscape for local anesthetic therapies

Recent years have seen transformative shifts that extend beyond simple product substitution, affecting the very modalities by which local anesthesia is developed, manufactured, delivered, and reimbursed. Advances in formulation technology have produced longer-acting and more targeted agents, while combination approaches and device-enabled delivery systems are enabling clinicians to tailor blocks to procedure-specific needs. Concurrently, heightened focus on opioid-sparing protocols and enhanced recovery after surgery pathways has prompted interdisciplinary collaboration that elevates the role of local anesthetics in multimodal analgesia strategies.

At the same time, digital health and perioperative analytics are beginning to influence both clinical decision support and commercial models. Real-world evidence collection and digital dosing tools facilitate more precise administration and post-procedural monitoring, which in turn informs payer conversations and hospital formularies. Supply chain transparency and regulatory scrutiny have intensified, prompting manufacturers to increase vertical integration or qualify multiple suppliers for critical raw materials. These shifts are compounded by changing care-site economics, where ambulatory surgery centers and home-based care models demand compact, user-friendly presentations and simplified administration pathways. Taken together, these dynamics create an environment where clinical efficacy, operational ease, and evidence-based value must converge for new local anesthesia products to achieve sustained adoption.

In-depth analysis of how the 2025 United States tariff measures have reshaped sourcing strategies, manufacturing footprints, and procurement decision-making for local anesthetic supply chains

The tariff landscape introduced in the United States in 2025 has had a cascading influence across manufacturing, sourcing, pricing strategies, and long-term supply chain planning for local anesthesia products. Immediate effects were felt in procurement, where increased import levies on active pharmaceutical ingredients and key excipients elevated landed costs and pressured margin profiles for manufacturers relying on global suppliers. In response, procurement teams accelerated qualification of alternative suppliers and expanded dual-sourcing strategies to mitigate exposure to single-country disruptions.

Longer-term implications include a renewed emphasis on regional manufacturing and nearshoring as companies evaluate trade-offs between landed cost volatility and fixed capital investments. Contract manufacturers and ingredient suppliers located outside tariff-impacted jurisdictions found opportunities to capture incremental demand, while manufacturers exposed to higher import duties began reconfiguring product portfolios to prioritize higher-margin or strategically differentiated formulations. Hospital and clinic procurement processes adjusted to reflect total cost of ownership rather than unit price alone, integrating inventory planning and supplier risk assessments into purchasing decisions.

Moreover, the tariff pressure intensified regulatory and quality assurance conversations, as rapid supplier changes necessitated comprehensive comparability studies and stability testing to support product integrity. Overall, the 2025 tariff actions catalyzed a strategic reassessment of sourcing, manufacturing footprint, and inventory policies, ultimately favoring manufacturers and distributors who could demonstrate supply chain transparency, regulatory compliance, and flexible production capacity.

Advanced segmentation insights synthesizing administration routes, drug classes, product types, formulations, end-user behaviors, distribution channels, and clinical applications to inform strategy

Segment-level dynamics reveal nuanced opportunities and constraints that inform product development and commercialization strategies. When viewed through the lens of route administration, clinical practice differentiates between infiltration techniques used for superficial procedures and nerve block approaches that require precise, longer-acting agents; regional and spinal administration demand products with predictable spread and minimal systemic toxicity; and topical formulations emphasize rapid onset and minimal irritation for dermatologic and minor dental applications. Each route carries distinct clinician training requirements, device compatibility considerations, and safety profiles that should influence formulation and packaging decisions.

Evaluating segmentation by drug class underscores how chemical families drive both clinical choice and formulation strategy. Amide-class agents such as bupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine offer varied onset and duration kinetics that inform selection for different procedures, while ester-class agents including benzocaine, procaine, and tetracaine maintain relevance in specific topical and short-duration contexts. Product-type segmentation stretches across creams, gels, injections, patches, and sprays, each presenting different regulatory pathways, patient acceptability factors, and device interfaces. Formulation choices-multi-dose vials, powders, pre-filled syringes, and single-dose ampoules-impact sterility assurance, dosing accuracy, and supply chain logistics, and therefore affect hospital adoption and ambulatory site preference.

End-user segmentation reveals differentiated procurement behaviors and clinical needs across ambulatory surgery centers, dental clinics, home care environments, and hospitals. Within ambulatory surgery centers, distinctions between free-standing and hospital-affiliated entities influence purchasing centralization and contract terms, while hospitals differentiated by private and public ownership exhibit divergent tendering practices and formulary governance. Distribution channels span hospital pharmacies, online pharmacies, and retail pharmacies; online pharmacy models include manufacturer-direct fulfillment and web aggregator platforms, while retail pharmacy distribution divides into chain and independent operators. Finally, application-specific segmentation-dental, dermatology, ENT, ophthalmic, and podiatry-drives demand for targeted formulation attributes, dose forms, and clinician education. Together, these layered segmentation lenses provide a strategic framework for prioritizing investments and tailoring commercial approaches to maximize clinical uptake and operational compatibility.

Strategic regional perspectives highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific markets differ in regulatory expectations, procurement practices, and clinical adoption

Regional variations continue to shape product priorities and go-to-market approaches in meaningful ways. In the Americas, a combination of advanced clinical infrastructure, high outpatient procedure volumes, and evolving payer expectations has increased emphasis on long-acting formulations, pre-filled systems, and solutions that support opioid-sparing care pathways. Supply chain strategies in this region reflect a balance between domestic manufacturing and reliance on established international suppliers, with procurement teams favoring partners who demonstrate regulatory compliance and logistical reliability.

The Europe, Middle East & Africa region presents a heterogeneous mix of regulatory environments and procurement models. Western European markets tend to emphasize rigorous clinical evidence and centralized formulary processes, whereas emerging markets in the Middle East and Africa prioritize cost-effective, robust products that tolerate variable storage and handling conditions. Reimbursement frameworks vary substantially across this region, making localized evidence generation and pricing strategies essential for adoption in public hospital systems and private clinics alike.

In Asia-Pacific, growth is driven by expanding surgical volumes, rapid uptake of ambulatory surgical models, and investments in local manufacturing capacity. Regulatory authorities are increasingly harmonizing requirements, yet country-specific clinical preferences persist, particularly regarding agent selection and presentation formats. Manufacturers targeting this region often combine regional production hubs with targeted clinician engagement and training programs to accelerate acceptance. Across all regions, partnerships with local distributors, investment in clinician education, and responsiveness to logistics challenges remain critical to securing sustainable access and uptake.

Illuminating competitive dynamics among innovators, generics manufacturers, contract producers, and device-integrated firms that are shaping the future landscape of local anesthetic development and commercialization

Company-level dynamics reflect a competitive interplay between innovators, generics manufacturers, contract producers, and integrated device-drug firms. Innovator organizations continue to invest in extended-release chemistries and proprietary delivery platforms that offer differentiation in duration, safety, or ease of administration. These investments are frequently supported by targeted clinical programs that demonstrate benefits in procedure-specific endpoints and patient-reported outcomes. At the same time, generics manufacturers maintain significant influence in commoditized segments, where cost-effectiveness and supply reliability drive purchasing decisions, particularly in high-volume applications such as dental and basic infiltration anesthesia.

Contract manufacturing organizations and specialty fill-finish partners have become strategic allies as the industry seeks flexible capacity and rapid scale-up capabilities. Device-drug combination players, particularly those offering pre-filled syringes, patches, or integrated delivery tools, are carving niches by addressing clinician workflow and dosing accuracy. Strategic partnerships, licensing arrangements, and selective acquisitions are common mechanisms firms use to extend portfolios, secure distribution channels, or access localized manufacturing capabilities. Across the competitive landscape, the most successful companies combine robust regulatory and quality systems with nimble commercial models and demonstrable clinical value propositions that resonate with hospital formulary committees and outpatient care purchasers.

Practical, prioritized recommendations for manufacturers, suppliers, and healthcare leaders to strengthen supply resilience, accelerate clinical adoption, and drive profitable growth

Industry leaders should pursue a set of prioritized, actionable moves to safeguard supply, accelerate adoption, and preserve margin. First, strengthen supplier diversification and inventory strategies to reduce exposure to trade policy volatility and single-source dependencies. Investing in regional or contract manufacturing options can create resilience while enabling faster responsiveness to local demand shifts. Second, align R&D priorities with clinical pathway needs by targeting formulations that demonstrably improve procedure efficiency, reduce opioid use, or simplify administration in ambulatory and home care settings; evidence packages that include patient-reported outcomes and health-economic modeling will facilitate payer and formulary conversations.

Third, optimize commercial approaches by pairing targeted clinician education with product formats that match care-site workflows, such as pre-filled syringes for high-throughput ambulatory centers or patches for dermatologic procedures. Fourth, explore partnerships and licensing deals with device manufacturers and digital health providers to create differentiated offerings that address both safety and usability. Fifth, incorporate total cost of ownership analyses into pricing and contracting to reflect inventory, wastage, and administration efficiencies rather than unit price alone. Finally, embed regulatory and quality-by-design principles early in product development to minimize comparability work when qualifying alternate suppliers and to accelerate approvals in multiple jurisdictions. Taken together, these recommendations balance near-term risk mitigation with medium-term growth and differentiation opportunities.

Robust mixed-methods research methodology integrating primary clinician and procurement interviews, regulatory and patent analysis, and supply chain mapping to validate insights

This research relied on a mixed-methods approach designed to ensure both breadth and depth in the analysis. Primary research included structured interviews with clinicians, purchasing leads, and supply chain managers across ambulatory and hospital settings to capture real-world preferences, pain points, and procurement criteria. Supplementing these qualitative inputs, regulatory reviews and product dossier analyses were performed to understand approval pathways, labeling differences, and post-marketing commitments across major jurisdictions. Manufacturing and sourcing assessments combined supplier mapping, capacity evaluations, and scenario analysis to examine resilience under trade policy and demand shocks.

Secondary research encompassed systematic reviews of peer-reviewed clinical literature, procedure volume data, and publicly available regulatory documents to triangulate clinical performance claims and safety profiles. Patent landscaping and intellectual property reviews informed the assessment of innovation lifecycles and freedom-to-operate considerations. Data quality assurance was achieved through cross-validation of primary interview themes with secondary sources and follow-up expert validation sessions. Limitations include potential variability in regional procurement practices and differences in country-level coding of procedure types; where relevant, regional caveats are explicitly stated. Methodological transparency and rigorous triangulation underpin the findings and recommendations presented in the report.

Concise concluding synthesis that connects clinical priorities, supply resilience, and commercialization imperatives to outline strategic imperatives for stakeholders

In conclusion, the local anesthesia landscape is simultaneously mature in its foundational science and dynamic in its commercial and operational evolution. Clinical imperatives around efficacy, safety, and duration continue to guide agent selection, while formulation innovation and delivery platforms provide meaningful opportunities for differentiation. Trade policy shifts and supply chain reconfigurations underscore the importance of supplier diversification and regional manufacturing strategies. Across regions and care settings, success will favor organizations that can align rigorous clinical evidence with practical administration formats and demonstrate clear value in terms of procedure efficiency and patient outcomes.

Decision-makers should prioritize investments that enhance supply resilience, streamline clinician workflows, and generate compelling real-world evidence. By adopting an integrated approach that spans R&D, manufacturing strategy, and localized commercialization, stakeholders can convert technical innovation into durable market access. The sectors poised for growth are those that marry clinical credibility with operational pragmatism, ensuring that new products not only perform in controlled trials but also scale effectively within the logistical and economic realities of contemporary healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of lipid-based local anesthetic formulations to reduce systemic toxicity risk
  • 5.2. Integrating digital monitoring platforms to optimize dosing and safety of local anesthetics
  • 5.3. Growing investment in long-acting anesthetic technologies for prolonged postoperative analgesia
  • 5.4. Adoption of ultrasound-guided nerve block procedures boosting demand for extended-release formulations
  • 5.5. Emergence of non-opioid multimodal analgesia protocols incorporating novel local anesthetics
  • 5.6. Rising regulatory approvals of safer novel amide-based anesthetics with reduced cardiotoxicity risk
  • 5.7. Increasing use of sustained-release anesthetic implants for chronic pain management in clinics
  • 5.8. Technological advances in transdermal delivery systems for precise localized dermal anesthesia applications
  • 5.9. Growth in decentralized compounding of personalized local anesthesia mixtures by specialty pharmacies
  • 5.10. Partnerships between pharma and medical device firms to develop smart anesthetic delivery technologies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Local Anesthesia Drugs Market, by Route Administration

  • 8.1. Infiltration
  • 8.2. Nerve Block
  • 8.3. Regional
  • 8.4. Spinal
  • 8.5. Topical

9. Local Anesthesia Drugs Market, by Drug Class

  • 9.1. Amides
    • 9.1.1. Bupivacaine
    • 9.1.2. Lidocaine
    • 9.1.3. Mepivacaine
    • 9.1.4. Prilocaine
    • 9.1.5. Ropivacaine
  • 9.2. Esters
    • 9.2.1. Benzocaine
    • 9.2.2. Procaine
    • 9.2.3. Tetracaine

10. Local Anesthesia Drugs Market, by Product Type

  • 10.1. Cream
  • 10.2. Gel
  • 10.3. Injection
  • 10.4. Patch
  • 10.5. Spray

11. Local Anesthesia Drugs Market, by Formulation

  • 11.1. Multi-dose Vial
  • 11.2. Powder
  • 11.3. Pre-filled Syringe
  • 11.4. Single-dose Ampoule

12. Local Anesthesia Drugs Market, by End-User

  • 12.1. Ambulatory Surgery Centers
    • 12.1.1. Free-standing
    • 12.1.2. Hospital-affiliated
  • 12.2. Dental Clinics
  • 12.3. Home Care
  • 12.4. Hospitals
    • 12.4.1. Private Hospitals
    • 12.4.2. Public Hospitals

13. Local Anesthesia Drugs Market, by Distribution Channel

  • 13.1. Hospital Pharmacy
  • 13.2. Online Pharmacy
    • 13.2.1. Manufacturer Direct
    • 13.2.2. Web Aggregators
  • 13.3. Retail Pharmacy
    • 13.3.1. Chain
    • 13.3.2. Independent

14. Local Anesthesia Drugs Market, by Application

  • 14.1. Dental
  • 14.2. Dermatology
  • 14.3. ENT
  • 14.4. Ophthalmic
  • 14.5. Podiatry

15. Local Anesthesia Drugs Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Local Anesthesia Drugs Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Local Anesthesia Drugs Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Pfizer Inc.
    • 18.3.2. Teva Pharmaceutical Industries Ltd.
    • 18.3.3. Viatris Inc.
    • 18.3.4. Sandoz International GmbH
    • 18.3.5. Fresenius Kabi AG
    • 18.3.6. Hikma Pharmaceuticals PLC
    • 18.3.7. B. Braun Melsungen AG
    • 18.3.8. Aspen Pharmacare Holdings Ltd.
    • 18.3.9. Amneal Pharmaceuticals, Inc.
    • 18.3.10. Sun Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LOCAL ANESTHESIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (